Latest News about RXRX
Recent news which mentions RXRX
Looking Into Recursion Pharmaceuticals's Recent Short Interest
September 16, 2024
Tickers
RXRX
From Benzinga
Decoding 6 Analyst Evaluations For Recursion Pharmaceuticals
September 04, 2024
Tickers
RXRX
From Benzinga
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
September 03, 2024
From Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
From Benzinga
Nasdaq Dips Over 2%; US Construction Spending Falls In July
September 03, 2024
From Benzinga
Recursion Pharmaceuticals Stock Is Sliding Tuesday: What's Going On?
September 03, 2024
From Benzinga
How Is The Market Feeling About Recursion Pharmaceuticals?
August 23, 2024
Tickers
RXRX
From Benzinga
From Motley Fool
From Motley Fool
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
August 12, 2024
From Motley Fool
From Motley Fool
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
August 08, 2024
From Benzinga
Tickers
RXRX
From InvestorPlace
From Motley Fool
Tickers
RXRX
From Motley Fool
25 Best Artificial Intelligence Stocks to Buy Right Now
July 25, 2024
From Motley Fool
3 Millionaire-Maker Artificial Intelligence (AI) Stocks
July 18, 2024
From Motley Fool
Tickers
RXRX
From Motley Fool
3 Healthcare Stocks Injecting AI for Big Gains
July 13, 2024
From InvestorPlace
From Benzinga
These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
July 12, 2024
From Motley Fool
From Motley Fool
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
July 08, 2024
From InvestorPlace
Why SoundHound AI Stock Lost 22% Last Month
July 08, 2024
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.